• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Announcement No 8, 2019/20

Luxor

Interim Report
1 October 2019 - 30 June 2020

The Supervisory Board of Investeringsselskabet Luxor A/S has today adopted the Interim Report for the period 1 October 2019 - 30 June 2020.

Third quarter 2019/20:

  • Basic earnings amount to DKK 10.8 million (DKK 6.5 million).
     
  • The Group’s profit before tax amounts to DKK 8.3 million (DKK 7.5 million).

Profit before tax for the quarter is DKK 2.5 million lower than basic earnings, primarily due to fair value adjustments of interest swaps and mortgage credit loans.

Interim period 2019/20:

  • Basic earnings for the period amount to DKK 31.4 million (DKK 22.4 million).
     
  • The Group’s profit before tax for the period amounts to DKK 35.4 million (DKK 15.9 million).

Profit before tax for the period is DKK 4.0 million higher than basic earnings, primarily due to:

  • fair value adjustments of interest swaps and mortgage credit loans of DKK 4.8 million;
  • fair value adjustments of financial assets and loss on sale of shares of DKK -0.8 million.

Expected basic earnings 2019/20:

  • For the financial year 2019/20, basic earnings of approx. DKK 38 million are expected, which is in accordance with the most recent announcement made in Company Announcement No 7 of 10 August 2020.
     
  • Fair value adjustments of interest swaps and financial assets are not included in basic earnings and will until 20 August 2020 affect results for the year before tax by DKK 4.8 million. The amount is distributed with DKK 3.9 million for the period and DKK 0.9 million for the period 1 July - 20 August 2020.

                       
To date, the Company’s basic earnings have not been materially affected by COVID-19.

The Company is to a certain extent dependent on the impact of COVID-19 on society and assesses on a current basis whether any adjustments are to be made based on this.

For additional information concerning this Interim Report, please contact Jannik Rolf Larsen, CEO
(tel: +45 3332 5015).

Attachment

  • fonds.medd. 30. juni 2020-UK